Browse > Article
http://dx.doi.org/10.9721/KJFST.2016.48.5.424

Screening of anti-obesity drugs, their analogues and prohibited ingredients in slimming foods  

Yun, Jisuk (New Hazardous Substance Team, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety)
Choi, Jangduck (New Hazardous Substance Team, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety)
Kwon, Kisung (New Hazardous Substance Team, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety)
Jo, Cheon-Ho (New Hazardous Substance Team, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety)
Publication Information
Korean Journal of Food Science and Technology / v.48, no.5, 2016 , pp. 424-429 More about this Journal
Abstract
Globally, obesity has been recognized as a serious health problem. Recently, slimming foods for weight loss and maintenance were found to contain anti-obesity drugs, their analogues, and prohibited ingredients. To avoid inspections by the Government, structurally modified analogs have been continuously synthesized. For rapid determination of adulterated slimming products, we simultaneously analyzed 21 illegal compounds using liquid chromatography (LC) equipped with photo diode array, and LC coupled with tandem mass spectrometry. The validation of the method was performed with regard to selectivity, linearity, limit of detection, limit of quantification, precision, and accuracy. We purchased 128 samples from the Korean market and online sources in the year 2015. In 31 samples, 3 illegal compounds were detected as follows: 9.9-135.3 mg/g of sibutramine, 0.2-17.5 mg/g of yohimbine, and 1.8 mg/g of icariin. This simultaneous detection method might prove to be a simple and rapid analysis for monitoring illegal compounds in slimming foods.
Keywords
illegal compound; anti-obesity drug; adulteration; obesity; slimming product;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Lee YC, Kim BS, Yun ES, Kim SD, Chang MS, Park YA, Shin Y, Jung SO, Lee JI, Chae YZ. Monitoring of forbidden medicines as adulterants in dietary supplements marketed online by HPLC and ESI-tandom mass spectrometry. Korean J. Food Sci. Technol. 44: 148-154 (2012)   DOI
2 Jang YM, Kim SY, Chang HS, Jang IH, Kim JI, Kim KH, Lee JH, Jung YK, Park J, Jeong D, Won S, Lee H, Shin D, Shin S, Lee JY, Kim ES, Kim OS, Lim MS, Hu SJ, Chae KR, Park SY, Kim EJ, Joo HJ, Lee JS, Han YJ, Cho JH, Lee HY. Monitoring and Elucidation of Novel Illegal Compounds in Foods about Compounds relative to Erectile Dysfunction Drugs and It's Analogues, Steroid Ingredients, and etc. Ministry of Food and Drug Safety. Cheongju, Korea. pp. 56-57 (2013)
3 Jang YM, Choi J, Chang HS, Kim JI, Yun J, Kim KH, Lee JH, Jung YK, Park J, Jeong D, Cho WJ, Won S, Kim J, Shin D, Lee H, Kim KW, Choi SO, Park MH, Lim MS, Kang N, Kim I, Shin J, Kim M, Cho JH, Lee JJ. Monitoring and Elucidation of Novel Illegal Compounds in Foods-about Compounds relative to Erectile Dysfunction Drugs and Their Analogues, Steroids, etc. Ministry of Food and Drug Safety. Cheongju, Korea. pp. 215 (2014)
4 Kwon K, Choi J, Jo CH, Yun J, Lee JH, Kang TS, Lee JH, Jung YK, Kim W, Kim JI, Shin D, Kim T, Won S, Park H, Cho WJ, Kim J, Choi SO, Chung SY, Chai JY, Oh MH, Cho JH, Lim MS, Kim EJ, Kim S, Kim E. Monitoring and Elucidation of Novel Illegal Compounds in Foods-with a Focus on Anti-impotence Drugs, Anti-obesity Drugs and Their Analogues. Ministry of Food and Drug Safety. Cheongju, Korea. pp. 244-246 (2015)
5 Luque CA, Rey JA. The discovery and status of sibutramine as an anti-obesity drug. Eur. J. Pharmacol. 440: 119-129 (2002)   DOI
6 Food and Drug Administration. Memorandum to the file NDA 20-632 Meridia (sibutramine hydrochloride monohydrate). Available from: http://www.fda.gov/downloads/drugs/drugsafety/ucm228795.pdf. Accessed May 25, 2016.
7 Ministry of Food and Drug Safety. Food Sanitation Law. Ministry of Food and Drug Safety. Cheongju, Korea. pp. 23-35 (2015)
8 Ministry of Food and Drug Safety. Food Code -Analytical Method II-. Ministry of Food and Drug Safety. Cheongju, Korea. pp. 1262-1281 (2015)
9 Choi D, Choi J, Park SK, Suh J, Ju S, Yoon T, Kim E, Han S . Safety Evaluation of Illegal Compounds in Food. Ministry of Food and Drug Safety. Cheongju, Korea. pp. 7-20 (2008)
10 Ministry of Food and Drug Safety. Food & Drug Statistical Yearbook. Ministry of Food and Drug Safety. Cheongju, Korea. pp. 51-52 (2015)
11 Association of Official Analytical Chemists. Appendix K: Guidelines for dietary supplements and botanicals. Available from: http://www.aoac.org/aoac_prod_imis/AOAC_Docs/StandardsDevelopment/ eoma_appendix_k.pdf. Accessed May 20, 2016.
12 Mans DJ, Gucinski AC, Dunn JD, Gryniewicz-Ruzicka CM, Mecker-Pogue LC, Kao J L-F, Ge X. Rapid screening and structural elucidation of a novel sibutramine analogue in a weight loss supplement: 11-Desisobutyl-11-benzylsibutramine. J. Pharm. Biomed. Anal. 83: 122-128 (2013)   DOI
13 Zeng Y, Xu Yimin, Kee CL, Low MY, Ge X. Analysis of 40 weight loss compounds adulterated in health supplements by liquid chromatography quadrupole linear ion trap mass spectrometry. Drug Test. Analysis 8: 351-356 (2016)   DOI
14 Kim HJ, Lee JH, Park HJ, Cho SH, Cho S, Kim WS. Monitoring of 29 weight loss compounds in foods and dietary supplements by LC-MS/MS. Food Addit. Contam. A 31: 777-783 (2014)   DOI
15 Tam SW, Worcel M, Wyllie M. Yohimbine: a clinical review. Parm. Therapeu. 91: 215-243 (2001)   DOI
16 McCarty MF. Pre-exercise administration of yohimbine may enhance the efficacy of exercise training as a fat loss strategy by boosting lipolysis. Med. Hypotheses 58: 491-495 (2002)   DOI
17 Kearney T, Tu N, Haller C. Adverse drug events associated with yohimbine-containing products: A retrospective review of the California poison control system reported cases. Ann. Pharmacother. 44: 1022-1029 (2010)   DOI
18 Corazza O, Martinotti G, Santacroce R, Chillemi E, Di Giannantonio M, Schifano F, Cellek S. Sexual enhancement products for sale online: Raising awareness of the psychoactive effects of yohimbine, maca, horny goat weed, and Ginko biloba. Biomed. Res. Int. 2014: 841798 (2014)